SMTL ID : 6gl8.1

Crystal structure of Bcl-2 in complex with the novel orally active inhibitor S55746

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

monomer

Ligands

1 x F3Q: ~{N}-(4-hydroxyphenyl)-3-[6-[[(3~{S})-3-(morpholin-4-ylmethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]-1,3-benzodioxol-5-yl]-~{N}-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide(Non-covalent)

F3Q.1: 14 residues within 4Å: Chain A: F.70, Y.74, D.77, F.78, M.81, Q.84, V.99, E.102, L.103, G.111, R.112, A.115, E.118, F.119 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:Y.74, A:Y.74, A:D.77, A:F.78, A:V.99, A:V.99, A:E.102, A:A.115, A:F.119, A:F.119 Hydrogen bonds: A:A.115 Water bridges: A:Y.74, A:R.112 Salt bridges: A:D.77 pi-Stacking: A:F.70, A:F.78

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Casara, P. et al., S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget (2018)

Release Date

2018-11-07

Peptides

Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-2,Bcl-2-like protein 1,Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-2